EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Epilepsy and migraine: a diagnostic and therapeutic challenge

Angelo Pascarella, Oreste Marsico, Domenico Abelardo, Roberta Cutellè, Alessandro Bulgari, Cataldo Mummolo, Anna Mammì, Vittoria Cianci, Umberto Aguglia, Edoardo Ferlazzo, Sara Gasparini

Frontiers in Pharmacology · 29.08.2025 · 16

DOI: 10.3389/fphar.2025.1649543 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.08.2025. Verfasst von Angelo Pascarella und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Magna Græcia University of Catanzaro, Catanzaro, Italy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Migraine and epilepsy are two common, chronic, disabling, paroxysmal neurological disorders. A growing body of evidence from epidemiological, genetic, neurophysiological, and clinical research suggests a complex, bidirectional association between them. Migraine prevalence in epilepsy patients ranges from 8% to 23%, while the reverse is noted at 1%–17%. Both disorders are underpinned by cortical hyperexcitability, dysfunctional neurotransmission, and impaired ion homeostasis. Shared genetic mutations, particularly in genes encoding ion channel subunits such as CACNA1A, SCN1A, and ATP1A2, further support a common channelopathy model. Cortical spreading depression, the electrophysiological substrate of migraine aura, and paroxysmal depolarization shift, a hallmark of epileptic activity, share converging features, including neuronal depolarization, potassium accumulation, glutamate release, and eventual firing suppression. Glial dysfunction, glutamatergic excitotoxicity, and mitochondrial deficits are additional unifying elements. Clinically, the differential diagnosis between migraine with aura and focal seizures remains challenging due to overlapping sensory, visual, and autonomic symptoms. Rare phenomena including ictal epileptic headache, postictal headache, and migraine-triggered seizures further complicate the clinical spectrum. Additionally, certain epilepsy syndromes, such as childhood epilepsy, are strongly associated with migraine. Early recognition of comorbidity is crucial for appropriate management, as tailored treatment strategies may improve outcome. Several antiseizure medications, including topiramate, valproate, lamotrigine, and perampanel, also demonstrate efficacy in migraine prophylaxis. Moreover, non-pharmacological approaches such as ketogenic diet, vagus nerve stimulation, and transcranial magnetic stimulation provide further evidence of a shared neurobiological substrate. This review explores the epidemiological, pathophysiological, and clinical intersections between migraine and epilepsy, a frequent and clinically relevant dilemma. Accurate differentiation is urgently needed to avoid therapeutic delays or inappropriate interventions, given their phenotypic mimicry. In addition, it highlights therapeutic implications driven by overlapping molecular mechanisms. Ongoing research is needed to further elucidate this relationship.

Schlagwörter

Stichwörter der Autor:innen

antiseizure medicationsauraheadachehemiplegic migrainemigralepsyseizure

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, Magna Græcia University of Catanzaro, Catanzaro, Italy.
  • Regional Epilepsy Centre, Great Metropolitan "Bianchi-Melacrino-Morelli Hospital", Reggio Calabria, Italy.
  • Department of Neuroscience, "Giovanni Paolo II" Hospital, Lamezia Terme, Italy.
  • Neurology Unit, Great Metropolitan "Bianchi-Melacrino-Morelli" Hospital, Reggio Calabria, Italy.

Förderung

  • Ministero dell'Università e della Ricerca

Zitieren

APA

Pascarella, A., Marsico, O., Abelardo, D., Cutellè, R., Bulgari, A., Mummolo, C., Mammì, A., Cianci, V., Aguglia, U., Ferlazzo, E., & Gasparini, S. (2025). Epilepsy and migraine: a diagnostic and therapeutic challenge. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1649543

Vancouver

Pascarella A, Marsico O, Abelardo D, Cutellè R, Bulgari A, Mummolo C, et al. Epilepsy and migraine: a diagnostic and therapeutic challenge. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1649543

BibTeX
@article{Pascarella2025,
  author = {Pascarella, Angelo and Marsico, Oreste and Abelardo, Domenico and Cutellè, Roberta and Bulgari, Alessandro and Mummolo, Cataldo and Mammì, Anna and Cianci, Vittoria and Aguglia, Umberto and Ferlazzo, Edoardo and Gasparini, Sara},
  title = {Epilepsy and migraine: a diagnostic and therapeutic challenge},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1649543}
}
Kostenlos starten →